Inventor · disambiguated record
Robert Rauchenberger
Also filed as: RAUCHENBERGER ROBERT
24 granted patents·5 pending applications·333 citations·filing 2001–2021
96Inventor score
Top patents by PatentIndex Score
29 records- 0198US7935344B2Human anti-IL-23 antibodies, compositions, methods and usesCENTOCOR ORTHO BIOTECH INC·Filed 2006·Granted May 3, 2011·93 cites·24 claims
- 0297US7993645B2Human anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2010·Granted Aug 9, 2011·57 cites·11 claims
- 0396US8106177B2Nucleic acids encoding human anti-IL-23 antibodiesBENSON JACQUELINE·Filed 2011·Granted Jan 31, 2012·34 cites·16 claims
- 0495US8221760B2Methods of treatment using human anti-IL-23 antibodiesBENSON JACQUELINE·Filed 2011·Granted Jul 17, 2012·29 cites·8 claims
- 0594US10030070B2Human anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2017·Granted Jul 24, 2018·11 cites·11 claims
- 0694US9783607B2Human anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2016·Granted Oct 10, 2017·10 cites·19 claims
- 0794US9353181B2Human anti-IL-23 antibodies, compositions, methods and usesBENSON JACQUELINE·Filed 2012·Granted May 31, 2016·22 cites·9 claims
- 0891US9522957B2Method of treating an inflammatory condition by administering toll-like 3 receptor antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 20, 2016·10 cites·7 claims
- 0990US9481731B2Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Nov 1, 2016·9 cites·10 claims
- 1090US9255153B2Polynucleotides encoding Toll-Like Receptor 3 antagonistsCUNNINGHAM MARK·Filed 2013·Granted Feb 9, 2016·10 cites·9 claims
- 1190US8519107B2IL-17A antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Aug 27, 2013·24 cites·16 claims
- 1282US9238693B2Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodiesCUNNINGHAM MARK·Filed 2013·Granted Jan 19, 2016·3 cites·9 claims
- 1380US8409567B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2009·Granted Apr 2, 2013·2 cites·17 claims
- 1478US12129293B2Medical device for administering anti-IL-23 antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Oct 29, 2024·0 cites·13 claims
- 1578US9932404B2Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonistJANSSEN BIOTECH INC·Filed 2016·Granted Apr 3, 2018·1 cites·18 claims
- 1678US8540986B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2010·Granted Sep 24, 2013·2 cites·9 claims
- 1778US7521047B2Human polypeptides causing or leading to the killing of cells including lymphoid tumor cellsGPC BIOTECH AG·Filed 2001·Granted Apr 21, 2009·11 cites·65 claims
- 1875US10954297B2Methods of treatment using human anti-IL-23 antibodiesJANSSEN BIOTECH INC·Filed 2018·Granted Mar 23, 2021·0 cites·10 claims
- 1973US9428577B2Platelet-derived growth factor B specific antibodies and compositions and uses thereofPFIZER·Filed 2013·Granted Aug 30, 2016·2 cites·7 claims
- 2073US8460659B2Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseasesCUNNINGHAM MARK·Filed 2011·Granted Jun 11, 2013·2 cites·5 claims
- 2172US10179810B2Anti-IGF antibodiesADAM PAUL·Filed 2014·Granted Jan 15, 2019·1 cites·18 claims
- 2271US11299538B2Anti-IGF antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Apr 12, 2022·0 cites·18 claims
- 2366US2018179294A1Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2461US2009325290A1Human polypeptides causing or leading to the killing of cells including lymphoid tumor cellsNAGY ZOLTAN·Filed 2009·Application pending·0 cites
- 2554US9856316B2Antibodies targeting M-CSFMORPHOSYS AG·Filed 2014·Granted Jan 2, 2018·0 cites·12 claims
- 2649US10081675B2Antibodies targeting M-CSFMORPHOSYS AG·Filed 2017·Granted Sep 25, 2018·0 cites·10 claims
- 2749US2014017250A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2013·Application pending·0 cites
- 2845US2008044420A1Anti-IL-13 antibodies, compositions, methods and usesHEAVNER GEORGE A·Filed 2006·Application pending·0 cites
- 2941US2013090457A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Rauchenberger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →